Lethal overdoses caused by psychoactive substances use in France


Lethal overdoses caused by psychoactive substances use in France

Tendances n° 70, OFDT, 4 p.
May 2010

The use of some drugs at certain doses can cause immediate or imminent death: this is what we call drug overdose death (see box below), which tends to affect relatively young people. A major objective of the policy of drug authorities in France and elsewhere is to reduce the number of these drug-related accidents that have dramatic consequences. This is why the data on drug overdose deaths constitute one of the five key indicators adopted by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
The question thus arises of how to define these overdoses and which causes of death to consider. In France, there are currently several sources of data that are built upon varying definitions. This issue also exists on a European level, since each country has adopted their own, specific modalities for registering these deaths. Therefore, the EMCDDA has committed itself to establishing a common protocol to be used by all members of the European Union (see box on the following page).
It seems necessary to describe these different sources in order to understand their scope and limitations, as well as to formulate the clearest view possible of the trends observed in drug overdose deaths according to these different information systems. Studying these data will also help suggest steps to take towards improving the situation in the future.

Authors :
Eric Janssen, Christophe Palle

Download the PDF file (131 Ko)







Drugs in Europe

2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.